Anti-androgen peptides and uses thereof in cancer therapy

Details for Australian Patent Application No. 2008228274 (hide)

Owner Cancer Research Technology Ltd

Inventors Migliaccio, Antimo; Auricchio, Ferdinando

Agent FB Rice

Pub. Number AU-A-2008228274

PCT Pub. Number WO2008/113770

Priority 60/895,424 16.03.07 US

Filing date 14 March 2008

Wipo publication date 25 September 2008

International Classifications

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/113770 Priority application(s): WO2008/113770

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008228296-Production of thorium 228 starting from a natural thorium salt

2008228269-Core-sheath particle for use as a filler for feeder masses